Across TCGA pan-cancer cohorts, RNA5SP243 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RNA5SP243’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RNA5SP243 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP243 is over-expressed in tumor.
COAD, BRCA, and BLCA are the cancer types where RNA5SP243 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP243 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.